Conformational dependence of the fluorescence of the FlAsH–TC-tagged mPrPs The fluorescence of the FlAsH reagent increased upon binding to the TC-tagged mPrP.. Addition of the native PrP
Trang 1between the native and converted forms
Jernej Gasˇpersˇicˇ1, Iva Hafner-Bratkovicˇ1, Michel Stephan2, Peter Veranicˇ3, Mojca Bencˇina1,
Ina Vorberg4and Roman Jerala1,5
1 Department of Biotechnology, National Institute of Chemistry, Ljubljana, Slovenia
2 Department of Organic and Medicinal Chemistry, National Institute of Chemistry, Ljubljana, Slovenia
3 Faculty of Medicine, Institute of Cell Biology, Ljubljana, Slovenia
4 Institute of Virology, TU Munich, Germany
5 Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia
Introduction
Prion diseases belong to a group of conformational
diseases characterized by the structural conversion of
native protein to alternative conformations [1] The
protein-only hypothesis states that prions are
com-posed predominantly of abnormally folded prion
pro-tein (PrP), the scrapie pathogenic form of PrP (PrPSc) [2] This form of PrP forms amyloid, which can be detected by compounds that bind to these types of ordered protein aggregate Molecules that bind specifi-cally to amyloids include thioflavin T (ThT) [3], Congo
Keywords
biarsenical; conversion; fibril; prion;
tetracysteine
Correspondence
R Jerala, Department of biotechnology,
National Institute of Chemistry, Hajdrihova
19, 1000 Ljubljana, Slovenia
Fax: +386 1 476 0300
Tel: +386 1 476 0335
E-mail: roman.jerala@ki.si
(Received 5 October 2009, revised 19
January 2010, accepted 17 February
2010)
doi:10.1111/j.1742-4658.2010.07619.x
The conformational conversion of prion protein (PrP) from a native con-formation to the amyloid form is a hallmark of transmissible spongiform encephalopathies Conversion is usually monitored by fluorescent dyes, which bind generic amyloids and are less suited for living cell imaging We report a new method for the synthesis of membrane-permeable and mem-brane-impermeable biarsenical reagents, which are then used to monitor murine PrP (mPrP) misfolding We introduced tetracysteine (TC) tags into three different positions of mPrP, which folded into a native-like structure Whereas mPrPs with a TC tag inserted at the N-terminus or C-terminus supported fibril formation, insertion into the helix 2–helix 3 loop inhibited conversion We devised a quantitative protease-free method to determine the fraction of converted PrP, based on the ability of the fluorescein arseni-cal helix binder reagent to differentiate between the monomeric and fibril-ized form of TC-tagged PrP, and showed that TC-tagged mPrP could be detected on transfected cells, thereby expanding the potential use of this method for the detection and study of conformational diseases
Structured digital abstract
l MINT-7709757 : Prp (uniprotkb: P04925 ) and Prp (uniprotkb: P04925 ) bind ( MI:0407 ) by elec-tron microscopy ( MI:0040 )
l MINT-7709744 : Prp (uniprotkb: P04925 ) and Prp (uniprotkb: P04925 ) bind ( MI:0407 ) by circular dichroism ( MI:0016 )
l MINT-7709730 : Prp (uniprotkb: P04925 ) and Prp (uniprotkb: P04925 ) bind ( MI:0407 ) by fluor-escence technology ( MI:0051 )
Abbreviations
BME, b-mercaptoethanol; CrAsH, carboxy fluorescein arsenical helix binder; EDT, ethane dithiol; FlAsH, fluorescein arsenical helix binder; GPI, glycosylphosphatidylinositol; H, helix; mPrP, murine prion protein; PrP, prion protein; PrPSc,scrapie pathogenic form of prion protein;
TC, tetracysteine; TCEP, Tris(2-carboxyethyl)phosphine; ThT, thioflavin T.
Trang 2red [4],
2-[1-(6-[(2-fluoroethyl)(methyl)amino]-2-naph-thyl)ethylidene]malononitrile [5], curcumin [6], and
luminescent conjugated polymers [7] Of these, ThT is
the most frequently used dye for detecting the
forma-tion of prion fibrils in vitro [8,9]
Localization of different proteins within living cells
became possible with the fusion of a fluorescent protein,
e.g green fluorescent protein, to the protein of interest
[10] Fluorescent protein domains may interfere with
protein folding or ligand binding and, more particularly,
with protein packing into ordered arrays Although the
green fluorescent protein fusion does not influence PrP
trafficking [11], it prevents prion infection [12], similarly
to the PrP–Fc fusion protein [13] A tetracysteine (TC)
tag that specifically binds biarsenic fluorescent dyes
rep-resents an alternative fluorescent labeling technique
A TC tag is a short peptide motif defined by the
sequence pattern CCXXCC, where C is a cysteine and
X any amino acid except cysteine [14] Fluorescein
arsenical helix binder (FlAsH) is an organoarsenical
compound that covalently binds to the TC tag at
subnanomolar concentrations [14] FlAsH is based on
fluorescein with two arsenic (III) atoms at the
4¢-posi-tion and 5¢-posi4¢-posi-tion, and is membrane-permeable
(Fig 1) This compound by itself is nonfluorescent [14]
Rigid spacing between both arsenic atoms in FlAsH
enables it to bind with high affinity and specificity to the
TC motif introduced into a variety of different proteins
[15] The binding of FlAsH reagent and also the
quan-tum yield of the formed FlAsH-peptide adduct depends
on the conformation of the peptide backbone adopted
by the tetracysteine tag [16] Tagging a protein with a
TC motif has been used for the detection of proteins
of interest in vivo [17,18], in purification [19], and for
detection on gel electrophoresis [15]
We decided to investigate the potential of
introduc-ing TC peptide tags at different positions on PrP in
order to monitor conformational changes in PrP We
show that insertion of a TC tag into the N-terminal and C-terminal segments of a protein does not inter-fere with fibril formation Fluorescent biarsenical reagents do not label the converted forms of PrP, but rather the native and denatured forms This property
is at the core of our new quantitative fluorescent con-version assay for PrP
Results Synthesis of FlAsH and carboxy FlAsH (CrAsH) The fluorescent reagents FlAsH and CrAsH, which bind to the TC peptide tag, have been previously reported on We modified the synthetic method described by Griffin et al [20] (Fig 1) The new practi-cal procedure limits the amounts of toxic reagents needed, and reduces the formation of byproducts by minimizing the number of manipulation steps during work-up Thus, starting from 4¢,5¢-bis(trifluoroacetoxy-mercuri)fluorescein, analytically pure FlAsH-ethane dithiol (EDT)2 was obtained in 29% yield (> 99% purity) after trituration with a minimal amount of
CH2Cl2 In addition, following the simplified proce-dure and starting from an approximately 1 : 1 mixture
of 4¢,5¢-bis(trifluoroacetoxymercuri)-5-carboxy-fluores-cein and 4¢,5¢-bis(trifluoroacetoxymercuri)-6-carboxy-fluorescein [21], an analytically pure mixture of 5-CrAsH-EDT2 and 6-CrAsH-EDT2 was obtained in 21% yield (> 99% purity) Both reagents were active and bound effectively to peptides containing the TC tag, as described below
Production, secondary structure analysis and thermal stability of the TC tag-modified protein Insertion of even a small peptide tag could affect the ability of PrP to convert to PrPSc We wanted to
Fig 1 Scheme of improved method of
chemical synthesis of FlAsH and CrAsH
reagents NMP, N-methyl-pyrolidinone;
RT, room temperature.
Trang 3investigate which positions within the tertiary
structure of PrP allow the introduction of a peptide
tag without compromising protein folding and
conversion into the fibrillar structure We selected
three positions: one at the disordered N-terminal
segment of PrP (TCN), another at the C-terminal
segment, which connects PrP to the
glycosylphos-phatidylinositol (GPI) anchor (TCC), and a third at
a position within the PrP structure between
helix (H)2 and H3 that is surface-exposed, provides
the geometry that would allow binding of the
biarsenical reagent via the thiol groups, and requires
the most conservative amino acid replacements
(TCL) (Fig 2A) All recombinant proteins were
produced in Escherichia coli in the form of inclusion
bodies, and successfully refolded into the native-like
conformation as judged by the far-UV CD spectra
Native murine PrP (mPrP) has a high content of
a-helical secondary structure, with characteristic
minima at 210 nm and 222 nm in the far-UV CD
spectrum The spectra of TCC, TCN and TCL
overlap the spectra of mPrP, indicating that the
secondary structure is conserved in all TC-tagged
mPrPs (Fig 2B, left) The thermal stabilities of
TC-tagged mPrPs determined by CD spectroscopy,
when we introduced a TC tag at the C-terminus
(64 ± 0.5C), at the N-terminus before octare-peats (67 ± 0.5C), or in the loop between H1 and H2 (63 ± 0.5 C), were not substantially different from the thermal stability of mPrP alone (65 ± 0.5C) (Fig 2B, right)
Conformational dependence of the fluorescence
of the FlAsH–TC-tagged mPrPs The fluorescence of the FlAsH reagent increased upon binding to the TC-tagged mPrP Addition of the native PrP without a TC tag did not cause an increase in FlAsH fluorescence, demonstrating that this increase is due to specific binding to the TC tag In prion disease, the native a-form of PrP is converted to oligomers and amyloid fibrils with a high b-sheet content [22,23] We investigated whether the introduction of a TC tag into PrP allows discrimination between the conformational states of PrP The fluorescence of the FlAsH–TC-tagged mPrP complex increased with increasing con-centration of urea for TCN (Fig 3A), TCL (Fig 3B), and TCC (Fig 3C), suggesting that the fluorescence of the protein–FlAsH adduct is stronger when it is in the denatured conformation This was in contrast to the measurements on the nonstructured TC-containing peptide, which retained approximately the same
121
Octarepeats TCN
23
A
B
230
TCC
α2
α1
α3
β3 β1
TCL
Fig 2 TC tag insertion does not signifi-cantly affect protein secondary structure or stability (A) Structural representation of TC tags inserted into mPrP based on the solu-tion structure (Protein Data Bank code: 1XYX [62]), with the unstructured domain represented by dots (B) Left: comparison of far-UV CD spectra of mPrP and its
TC-tagged counterparts shows that the secondary structure is conserved in TC-tagged mPrPs Right: the thermal stability of TC-tagged mPrPs demonstrates similar melting temperatures Scans were obtained at protein concentrations of 0.1 mgÆmL)1in MilliQ water, with a temperature scan rate of 1 CÆmin)1, monitored by the ellipticity at 215 nm.
Trang 4fluorescence regardless of the concentration of the
dena-turing agent, ruling out the solvent effect of the
denatur-ing agent on the FlAsH fluorescence (Fig 3D)
Several studies have shown transient interactions
between the flexible N-terminus and globular domain
[24–26] and ordering of the N-terminal octarepeats
above pH 6.5 [27], so the increase in fluorescence of
the FlAsH–TCN adduct with increasing denaturant
concentration could result from the change in the local
chemical environment of the PrP As a negative
con-trol, FlAsH fluorescence was measured in the presence
of increasing concentrations of denaturants with
(Fig 3E) or without (Fig 3F) mPrP One possible
explanation for the increase in FlAsH fluorescence
with increasing concentration of denaturant might be
that FlAsH binds more efficiently to the denatured
PrP than to the folded protein and that the higher
flu-orescence occurs because of additional binding under denaturing conditions However, we obtained the same effect when FlAsH was initially bound to the protein under denaturing conditions, and a lower final concentration of denaturing agent was obtained by dilution (Fig 3A–C) This demonstrates that TC tags
on PrP and FlAsH represent a conformation-sensitive probe
A TC tag at the N-terminus or C-terminus of PrP does not prevent conversion
We investigated whether the TC tag interferes with PrP conversion Fibril formation under mildly denatur-ing conditions [28] was monitored with the amyloid-specific dye ThT We showed that TCC and TCN formed fibrils, whereas TCL, which also folded into a
A
B
C
D
E
F
Fig 3 FlAsH fluorescence of TC-tagged
mPrP depends on the conformational state
of the protein The fluorescence of TCN (A),
TCL (B) and TCC (C) in the presence of
FlAsH was measured as a function of
con-centration of urea (s) In parallel, conjugates
of PrPs with FlAsH were formed in 8 M
urea, and diluted to the final concentration
of urea as indicated ( ) The fluorescence of
FlAsH bound to the short TC peptide
DDCCPGCCDD did not depend on the
pres-ence of denaturant (D) Control reactions
with mPrP without TC tag in the presence
of FlAsH (E) and FlAsH itself (F) do not
exhibit fluorescence.
Trang 5native-like conformation, did not form fibrils within
4 days (Fig 4A) mPrP, TCN and TCC changed into
the b-structured conformation, whereas TCL remained
in the a-monomeric conformation (Fig 4B) TCN and
TCC fibril formation were also confirmed by
transmis-sion electron microscopy (Fig 4C), which showed
fibrils similar in size and morphology to those of
wild-type mPrP
Detection of TC-tagged mPrPs in cell culture
We introduced TC-tagged and non-TC-tagged mPrP
into the PrP-deficient cell line HpL3-4 Introduced
mPrPs additionally harbored mutations L108M and
V111M, enabling recognition by antibody 3F4
Although both TCC (Fig 5Ab) and TCN (Fig 5Ac)
were expressed at the cell surface, we had difficulties in
obtaining specific labeling with FlAsH using previously
published protocols [16,20,29–33] However, with a
modified protocol by Taguchi [34], the specific labeling
of TCC (Fig 5Bb) and TCN (Fig 5Bc) with FlAsH was
achieved We also used the CrAsH, which is similar to
FlAsH but contains an additional charged group and is
not membrane-permeable, to label only surface-exposed
TCC (Fig 5Cb) and TCN (Fig 5Cc) [35] No surface
FlAsH or CrAsH labeling was observed in HpL3-4
transduced with PrP without a TC tag (Fig 5Ba,Ca)
FlAsH fluorescence discriminates native from
fibrillar mPrP
As we had demonstrated that TCC and TCN have the
ability to be converted into fibrils, we investigated
FlAsH fluorescence in combination with the native or fibrillar form of TC-tagged PrP FlAsH binding and its fluorescence was followed in parallel with ThT fluo-rescence during fibril formation We found that FlAsH selectively bound to the native forms of TCN and TCC and exhibited fluorescence In the presence of TCN and TCC fibrils, however, FlAsH exhibited no fluorescence (Fig 6A,C) The fluorescence of ThT was inversely proportional to the fluorescence of FlAsH When amyloid started to form, ThT fluorescence increased, and at the same time FlAsH fluorescence decreased along with the amount of monomeric PrP
In the case of TCL, which does not form fibrils, both ThT and FlAsH fluorescence remained unchanged (Fig 6B) This phenomenon could be explained in two ways: either FlAsH does not bind to the fibrillar form
of TCN and TCC, because the TC tag becomes inac-cessible to the reagent; or the cysteines of the TC tag become oxidized during fibril formation However, the addition of a reducing agent to PrP fibrils did not result in enhanced FlAsH fluorescence intensity (data not shown), and the addition of FlAsH to nonconvert-ing TCL resulted in fluorescence under the same reac-tion condireac-tions Thus, we conclude that the TC tag in fibrils becomes inaccessible to FlAsH This is also sup-ported by the finding that fibrils made from TCC pre-labeled with FlAsH under native conditions retained their fluorescence (Fig 6D)
Quantitative fluorescent PrP conversion assay
We showed that TC-tagged PrP and FlAsH represent
a sensor for PrP conversion This phenomenon could
A
C
B
Fig 4 Conversion of TC-tagged PrPs (A) The kinetics of fibril formation of mPrP ( ), TCC ( ), TCN (•) and TCL (.) in microtiter plate assays were monitored by the fluores-cence of ThT TCC and TCN formed amy-loid, whereas TCL did not undergo conversion (B) CD spectra of converted PrP show that mPrP, TCC and TCN were converted to the b-form, whereas TCL remained in the a-conformation (C) Formation of PrP fibrils of TCC, TCN and mPrP was confirmed by transmission electron microscopy.
Trang 6be used to quantify PrP conversion without the need
to perform proteolytic digestion of converted PrP,
which is the basic principle of most conversion assays
We have devised an assay to determine the fraction of
converted PrP, based on the difference in fluorescence
between the monomeric and fibrillar forms of TCC
FlAsH detects only the amount of nonconverted
TC-tagged PrP In order to obtain an accurate result
for the conversion efficiency, we needed to normalize
the reading of the nonconverted TC-tagged PrP
against the total amount of TC-tagged PrP in the
sam-ple This can be determined by solubilizing all, i.e
con-verted and nonconcon-verted, TC-tagged PrP into the
soluble denatured form by using 6 m guanidine
hydro-chloride and 10 mm dithiothreitol The denatured form
was fluorescent, owing to the binding of FlAsH, and
was used to determine the amount of total TC-tagged
PrP from the calibration curve for the unfolded
pro-tein (Fig 7C) We showed that mixtures of different
ratios of converted and native TC-tagged PrP showed
a linear response over the whole range (Fig 7D), thus providing a method for detecting TC-tagged PrP conversion without the need to employ proteolytic digestion
Discussion Different fluorescent tags have revolutionized protein science and cell biology However, large and slow-fold-ing fluorescent proteins may influence the foldslow-fold-ing of their fusion partner, and, in the case of prion disease and other conformational diseases, they may interfere with conformational conversion, as demonstrated for PrP [11,12] Therefore, small, genetically encoded tags may prove more useful in prion research, particularly with cell culture assays for testing prion infectivity [36,37]
We introduced a TC tag, enabling the selective incorporation of biarsenical fluorophores into different positions on PrP Ideally, tags should not affect
0 µm 25
0 µm 25
A
B
C
Fig 5 Fluorescent biarsenical compounds
specifically label TC-tagged PrPs expressed
in the PrP-deficient cell line HpL3-4 (A)
mPrP (a), TCC (b) or TCN (c) are expressed
at the cell surface, as judged from flow
cytometry analysis using 3F4 as primary
antibody (white) Cells stained only with
Cy2-conjugated secondary antibodies were
used as controls (gray) Cells were stained
with FlAsH (B) or CrAsH (C), and imaged
under the confocal microscope In cells that
express TCC (Bb and Cb) and TCN (Bc and
Cc), FlAsH and CrAsH selectively stain the
cell surface, whereas there is no staining of
the cells expressing mPrP (Ba and Ca)
protein.
Trang 7protein stability or trafficking, and should not interfere
with prion misfolding We avoided introducing TC
tags into segments around the residues that had been
previously shown to contribute to the species barrier
[38] or that show a different susceptibility to prion
strains, with the aim of developing a test with broad
applicability None of the three introduced TC tags
substantially affected protein secondary structure
mPrPs with TC tags inserted at the N-terminus or
C-terminus were able to undergo conversion, whereas
introduction of a TC tag into the loop between H2
and H3 prevented fibril formation TCN and TCC
seem to undergo fibrillization even faster than mPrP,
and we are currently investigating the mechanism of
this phenomenon Although antibody studies [39] and
some PrPScmodels [40,41] do not predict that the
seg-ment in the loop between H2 and H3 will undergo a
conformational change, some human pathogenic
muta-tions, such as E196K [42], indicate that this segment
might influence PrP misfolding We speculate that this
segment forms contacts with other monomers in the
core of the fibrils, although PrP has been previously
shown to be sensitive to point mutations throughout
its compact domain
Biarsenical reagents have great potential as
molecu-lar sensors, particumolecu-larly as improved cell-staining
pro-cedures allow a high signal-to-background noise ratio
The new simplified synthetic procedure reported here
may allow researchers to prepare reagents to stain
either all cellular TC-tagged proteins or only a subset
exposed at the cell surface We used a modified cell-labeling method [34] to show that FlAsH and CrAsH specifically label TC-tagged PrPs CrAsH is particu-larly suitable for following the trafficking of PrPs and other TC-tagged extracellular proteins, as it does not cross the cell membrane, owing to the presence of charged groups, and its fluorescence is more stable at physiological pH [35]
FlAsH fluorescence increased with protein denatur-ation, showing that FlAsH in the context of PrP is a conformation-sensitive probe This is similar to what was found in a previous study, where FlAsH fluores-cence increased upon unfolding of TC-tagged cellular retinoic acid-binding protein I [16] On the other hand, under PrP conversion conditions, FlAsH fluorescence decreased with an increase in ThT fluorescence, which marks the formation of amyloid fibrils As the pre-sence of reducent did not reconstitute FlAsH binding
to fibrils (data not shown), the best explanation is that the TC tag in fibrils of TCN and TCC is not accessible
to FlAsH, and that both the N-terminal and C-termi-nal regions are buried within the formed fibrils This is
in agreement with the results of antibody-binding stud-ies [43,44] Additionally, a GPI anchor attached to the C-terminus of PrPSc cannot be cleaved by phospholi-pase C, indicating that this PrP segment is protected after formation of the protease-resistant form of PrP [45], which is in accordance with our results An MS study showed that the flexible N-terminus is highly protected in fibrils in comparison to native PrP [46]
0 µm 25
D C
Fig 6 FlAsH follows the conversion of TCC and TCN in an inversely proportional manner relative to ThT Structural conversion of TCN (A), TCL (B) and TCC (C) was followed by ThT ( ) and FlAsH fluorescence (s) Aliquots of the fibril formation mixture were taken at the indicated times Samples were incubated with FlAsH for 2 h at room tem-perature, with 1 m M TCEP, 1 m M BLE and
50 m M Hepes (pH 7.5) prior to fluorescence measurement The fluorescence intensity at emission maxima (kFlAsH= 528 nm,
k ThT = 474 nm) is plotted against conversion time The FlAsH–TCC adduct was prepared prior to fibril formation, and left to undergo conversion for 48 h Fluorescent aggregates were visualized by confocal microscopy (D).
Trang 8Recently Coleman et al [47] observed an increase in
FlAsH fluorescence when it was bound to oligomeric
PrP as compared with a-structured PrP In their
con-struct, a TC tag was introduced into the hydrophobic
domain of PrP, N-terminally to the structured domain
This region has been shown to participate in the
amy-loid core [41,48–50], so it is possible that their result
was a consequence of observing b-oligomers, as the
presence of mature fibrils has not been demonstrated
We used the selectivity of FlAsH fluorescence
between the native and converted forms of TC-tagged
PrP as the basis of a new quantitative fluorescent PrP
conversion assay (Fig 7B) Most assays for PrP
conver-sion are based on the proteolytic degradation of PrP by
proteinase K, which is time-consuming and, above all, has to be carefully calibrated for the amount of the active protease and the duration and reaction condi-tions of digestion, which can significantly affect the result [36,51] In our assay, we can quantify the amount
of nonconverted TC-tagged PrP by measuring the fluo-rescence after the addition of FlAsH The total initial amount of TC-tagged PrP in the sample required for the normalization and comparison between different samples can be determined from the FlAsH fluores-cence of the solubilized and unfolded PrP (Fig 7A) The principle of our described assay is similar to that of the conformation-dependent immunoassay [52], where one set of antibodies is used to detect the amount of
23
23
A
D
Fig 7 Quantitative fluorescent PrP
conver-sion assay (A) Schematic illustration of the
principle of the assay: under native
condi-tions, only native PrP exhibits fluorescence
(indicated by a star), whereas after the
addition of denaturant, all forms of PrP are
solubilized and exhibit FlAsH fluorescence.
(B) Fluorescence emission spectra of the
native and converted form of TC-tagged PrP
(TCC) in the presence of FlAsH (C)
Fluores-cence of converted and nonconverted PrP in
the presence of 6 M guanidine hydrochloride
and 10 m M dithiothreitol (D) Samples with
different fractions of converted PrP were
prepared by mixing converted and native
TCC FlAsH fluorescence was determined
under native conditions, and normalized by
the fluorescence under the denaturing
con-ditions of each sample divided by the
fluo-rescence of native PrP under the denaturing
conditions, displaying a linear response.
Trang 9nonconverted PrP, and the total amount of PrP,
unfolded in the presence of denaturing agent, is
deter-mined using the second set of antibodies The described
method could be particularly useful in research
requir-ing fast results, such as in kinetic and structural studies
of PrP intermediates, for in vitro conversion, such as in
an amyloid seeding assay [9] and protein misfolding
cyclic amplification [53,54], and potentially also in
diag-nostics in cell-based assays based on the reporter cell
line producing the TC-tagged PrP [55]
Experimental procedures
Materials
The 3F4 antibodies were purchased from Dako (Glostrup,
Denmark), Cy2-conjugated anti-mouse IgG from Dianova
(Hamburg, Germany), pRSET A plasmid from Invitrogen
(Madison, WI, USA), the Quikchange kit from Stratagene
(La Jolla, CA, USA), and Ni2+–nitrilotriacetic acid resin
from Qiagen (Hilden, Germany) Guanidine hydrochloride
and urea were purchased from Fluka (Buchs, Switzerland)
All other chemicals were purchased from Sigma (St Louis,
MO, USA)
Preparation of TC-tagged PrP constructs
TC tags were introduced into three positions on 3F4-tagged
murine PrP (L108M⁄ V111M) In TCC, CCPGCC was
inserted after Ser231 Mutations in TCL were T192C,
T193C, K194P, E196C, and N197C Mutations in TCN
were R37C, Y38C, Q41C, and G42C (Fig 2A)
Insertions were introduced into the 3F4-tagged mPrP
ORF (from 23 to 230 amino acids) cloned into plasmid
pRSET A (Invitrogen) with a Quikchange kit (Stratagene),
using specific sense and complementary antisense
oligonu-cleotides, as follows: for TCC sense, 5¢-GGG CGT CGT
TCC AGC TGT TGT CCG GGT TGT TGT TAA GAA
TTC GAA GC-3¢; for TCC antisense, 5¢-GC TTC GAA
TTC TTA ACA ACA ACC CGG ACA ACA GCT GGA
ACG ACG CCC-3¢; for TCN sense, 5¢-AAC ACC GGT
GGA AGC TGT TGT CCT GGT GTT GTA GCC CTG
GAG GCA AC-3¢; for TCN antisense, 5¢-GT TGC CTC
CAG GGC TAC AAC ACC AGG ACA ACA GCT TCC
ACC GGT GTT-3¢; for TCL sense, 5¢-CAC ACG GTC
ACC ACC TGC TGC CCG GGG TGC TGC TTC ACC
GAG ACC GAT-3¢; and for TCL antisense, 5¢-ATC
GGT CTC GGT GAA GCA GCA CCC CGG GCA GCA
GGT GGT GAC CGT GTG-3¢
Protein expression, purification, and refolding
Plasmid pRSET A, encoding mPrP (or TC-tagged mPrP:
TCN, TCL, or TCC), was transformed into competent
E coliBL21(DE3) pLysS, and mutated PrPs were expressed
in the form of inclusion bodies The protein was purified and refolded on an Ni2+–nitrilotriacetic acid column, using a similar procedure to one previously described [6,56] The pur-ity of the isolated protein was checked by SDS⁄ PAGE
Conversion to the fibrillar form of PrP
Proteins were denatured overnight in 6 m guanidine hydro-chloride at 4C The amyloid form of mPrP was produced
by diluting denatured mPrP and TC-tagged mPrP with 1 m guanidine hydrochloride, 3 m urea and NaCl⁄ Pi(pH 6.8) at protein concentrations of 20 lm, and shaking at 37C [28] The amyloid form of PrP in 96-well microtiter plates was produced by an identical protocol, and three 3⁄ 32 teflon balls were also added to each well for better shaking [57] FlAsH cannot bind to the formed fibrils; however, labeled PrP fibrils can be prepared by conversion of the FlAsH-labeled PrP (TCC), as the label does not hinder con-version FlAsH was added to native TCC at a 2 : 1 ratio,
in a reaction mixture containing 50 mm Hepes, 1 mm Tris(2-carboxyethyl)phosphine (TCEP), and 1 mm b-mer-captoethanol (BLE) The reaction solution was incubated
at room temperature for 2 h, protected from light Fibrils made from FlAsH-labeled TCC were made using an identi-cal protocol to the one described above
Electron microscopy
Holey formvar carbon-coated copper grids (SPI Supplies) were coated with 0.1% poly(l-lysine) and placed on one drop of the protein sample for 3 min Samples on grids were negatively stained with 1% (w⁄ v) aqueous uranyl ace-tate, and observed on a Jeol 100CX electron microscope operating at 80 keV
CD spectroscopy
CD spectra were recorded on an Applied Photophysics Chirascan spectropolarimeter under nitrogen flow Far-UV
CD spectra for protein secondary structure determination were recorded between 190 nm and 260 nm in a 0.1 cm pathlength cuvette at a protein concentration of 0.1 mgÆmL)1, using steps of 0.5 nm with 1 s per point The temperature stability of proteins was recorded in a 0.1 cm pathlength cuvette (300 lL) at a protein concentra-tion of 0.1 mgÆmL)1 with a temperature scan rate of
1CÆmin)1 at 215 nm Spectra were smoothed by software supplied with the instrument
Fluorescence spectroscopy
For fluorescence measurements, a Perkin Elmer LS55 fluo-rimeter was used ThT emission (460–535 nm) was tracked
Trang 10by excitation at 442 nm with a protein concentration of
1 lm and 10 lm ThT
The fluorescence of FlAsH was monitored between
510 nm and 560 nm with excitation at 508 ± 5 nm in a
0.3 cm pathlength cuvette FlAsH (5 lm) was incubated at
room temperature for 2 h with 5 lm protein or peptide in
the presence of 1 mm BME and 1 mm TCEP in 50 mm
Hepes (pH 7.5) [16]
Conversion calculation
The amount of converted PrP was calculated from the
fluo-rescence intensity values of the sample after the 1 h
incuba-tion period in the presence of 10 lm FlAsH, 1 mm TCEP,
1 mm BME, and 50 mm Hepes (pH 7.5), and after reading
of the same sample after the addition of 6 m guanidine
hydrochloride, 10 mm dithiothreitol, 50 mm Hepes
(pH 7.5), and 10 lm FlAsH The amounts of native and
denatured PrP were read from the calibration curve
obtained with different amounts of PrP under native and
denaturing conditions in the presence of FlAsH, in both
cases with subtracted fluorescence of sample with FlAsH
without TC-tagged prion protein
The percentage of converted PrP was calculated using the
equation
fraction converted¼ ðPrPtot PrPnatÞ=PrPtot
where PrPnat represents the nonconverted amount and
PrPtot the total amount (converted plus nonconverted) of
PrP
Construction of retroviral plasmids, production of
retrovirions and transduction of the HpL3-4 cell
line, and flow cytometry
TC tags were introduced into the 3F4-tagged mPrP ORF in
pcDNA3.1zeo(+) by Quikchange mutagenesis (Stratagene)
Whereas the N-terminal TC tag was prepared using the
same oligonucleotides as given above, sense (5¢-TCC
CAG GCC TAT TAC TGT TGT CCA GGA TGT TGT
GAC GGG AGA AGA TCC-3¢) and antisense (5¢-GGA
TCT TCT CCC GTC ACA ACA TCC TGG ACA ACA
GTA ATA GGC CTG GGA-3¢) oligonucleotides were used
to insert the TC tag before the GPI attachment signal
Mutant mPrP ORFs were subcloned into the retroviral
expression vector pSFF [58–60] The pSFF vectors were
transfected into a coculture of packaging cell lines w2 and
PA317 When cells were more than 80% positive for PrP,
retroviral supernatants were harvested and cleared by
cen-trifugation (120 g, 4C, 10 min) HpL3-4 cells (3 · 105per
well) [61] were plated into six-well microtiter plates 1 day
before transduction Cells were incubated with polybrene
(4 lgÆmL)1) 2 h before addition of the retrovirions One
milliliter of retroviral supernatant was incubated with the
cells for 2 days, after which the cells were transferred to a
6 cm or 10 cm culture plate
We used a flow cytometry protocol adapted from Maas et al [37] to check whether TC-tagged proteins are expressed at the cell surface of HpL3-4 cells similarly to wild-type PrP Cells (5· 105
per tube) were first incubated with FACS buffer (2.5% fetal bovine serum in NaCl⁄ Pi) for 10 min at 4C One hundred microliters of 3F4 anti-body (5 lgÆmL)1; Dako) was added to the cells and incu-bated for 45 min at 4C After washing, the cells were incubated with Cy2-conjugated anti-mouse IgG as second-ary antibodies (Dianova) for 45 min at 4C in the dark Rinsed cells were analyzed by flow cytometry
Cell labeling with biarsenical compounds
Cells were stained with FlAsH (CrAsH) using an adapted protocol [34] Cells were incubated in l-Slide eight-well slides (iBidi) overnight Prior to staining, FlAsH (CrAsH) was preincubated with 0.8 m dithiothreitol and 5 mm EDT for 5 min at room temperature Cells were washed with HBSS and stained for 1 min with 1.3 lm FlAsH (CrAsH) and 15 mm dithiothreitol in HBSS Unbound FlAsH (CrAsH) was rinsed off with HBSS Cells were fixed either with 4% paraformaldehyde or ice cold ()20 C) methanol for at least 5 min
Confocal microscopy
Images were obtained on a Leica TCS SP5 laser scanning microscope mounted on a Leica DMI 6000 CS inverted microscope (Leica Microsystems, Germany) with an HCX plan apo ·63 oil (numerical aperture: 1.4) oil immersion objective For excitation, the 514 nm line of a 25 mW argon laser was used As laser power of 5% was used for the argon laser Fluorescence emission was detected at 530–560 nm
Acknowledgements
We would like to thank D Oven and R Rost for excellent technical assistance We are grateful to
A Aguzzi for the plasmids for mPrP expression,
S A Priola and B Chesebro for providing the w2 and PA317 cells and the vector pSFF, and T Onodera for the HpL3-4 cells We would like to thank C Taft for careful reading of the manuscript The authors acknowledge financial support from the state budget
by the Slovenian Research Agency This project was supported by the 6th framework EU project, TSEUR
References
1 Stefani M (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark